| Serial Number | 79368363 |
| Word Mark | I-BODY |
| Filing Date | Tuesday, April 4, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Friday, September 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, biological preparations for the treatment of fibrosis, cancer and other diseases; Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, prescription injectable pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, prescription injectable biological preparations for the treatment of fibrosis, cancer and other diseases, inhaled pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, inhaled biological preparations for the treatment of fibrosis, cancer and other diseases; diagnostic preparations and reagents for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody fragments for combining with other chemicals, proteins and cells for medical or diagnostic purposes; antibody conjugates for medical purposes; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for medical research use in the development of monoclonal antibodies for medical purposes; molecular targets for drug and vaccine development, all in the nature of biological reagents for medical research use; tagged antibodies for medical research and medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes, namely, for capturing, imaging, detecting, identifying or characterising protein and cell therapeutic candidates; reagents for use in diagnostic tests for medical purposes; reagents for medical research applications for medical diagnosis; biological tissue, namely, recombinant human protein production cell line for medical use or modified human cells for therapeutic use; biological tissue, namely recombinant human protein production cell line for modified human cells for therapeutic use; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology for medical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AdAlta Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Event Date | Event Description |
| Thursday, April 27, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, January 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 2, 2023 | APPLICATION FILING RECEIPT MAILED |
| Saturday, December 30, 2023 | ASSIGNED TO EXAMINER |
| Thursday, January 11, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, January 12, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, January 29, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, February 19, 2024 | REFUSAL PROCESSED BY IB |
| Monday, July 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 13, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, September 13, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, July 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 13, 2024 | SUSPENSION LETTER WRITTEN |
| Wednesday, September 25, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 25, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |